12th Edition of International Conference on Neurology and Brain Disorders
October 20-22, 2025
Brain Tumors
Brain tumors manifest as abnormal growths within the brain or its surrounding structures, potentially arising from diverse cell types like glial cells, neurons, or meninges. These growths can be categorized as either benign or malignant, with the latter having the capacity to infiltrate neighboring tissues and metastasize. Symptoms vary widely based on factors such as tumor size, location, and growth rate. Common manifestations encompass persistent headaches, seizures, alterations in vision or hearing, cognitive decline, and shifts in personality. Diagnosis typically entails a blend of imaging modalities like magnetic resonance imaging (MRI) or computed tomography (CT) scans, followed by biopsy for precise classification and grading. Treatment strategies hinge on variables such as tumor location, size, grade, and patient health status and preferences. Options may encompass surgical excision, radiation therapy, chemotherapy, targeted drug therapy, or a combination thereof. Supportive measures, including steroid administration or anticonvulsants, are sometimes employed to alleviate symptoms and enhance quality of life.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
Thomas J Webster
Interstellar Therapeutics, United States
Roger H Coletti
Interventional Health, PA, United States
Stephen Grossberg
Boston University, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Krishna Moorjani, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Abhay Murthy, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signalling
Ethan Liu, Boston University, United States